Sage Journals: Discover world-class research

Retricted access

Article commentary

First published 2022-1

Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer

Jacopo Giuliani, Beatrice Mantoan, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

Encorafenib plus cetuximab for the treatment of BRAF-V600E -mutated metastatic colorectal cancer

Javier Ros, Nadia Saoudi, Iosune Baraibar [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Pharmacist tailored monitoring for patients initiating encorafenib and binimetinib combination therapy

Brooke D. Looney, Stephanie G. White, Josh DeClercq [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-04

A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan

Makoto Tahara, Naomi Kiyota, Hiroo Imai [...]

Thyroid®

Open access

Review article

First published 2021

BRAF,MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

Javier Ros, Iosune Baraibar, Emilia Sardo [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-3

Ophthalmic adverse effects of BRAF inhibitors

Clara M. Castillejo Becerra, Wendy M. Smith, Lauren A. Dalvin

European Journal of Ophthalmology

Retricted access

Correction

First published 2025-10

Corrigendum to: A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan

Thyroid®

Free access

Case report

First published 2024-1

Visual symptoms in a patient treated with MEK inhibitors

Tommaso Tibaldi, Gabriele Roccuzzo, Alessandra Fazio [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2023-9

Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

Shiraz Halloush, Nimer S. Alkhatib, Abdulaali R. Almutairi [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2025

Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy

Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti [...]

Therapeutic Advances in Medical Oncology

Search results